Mather Group’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.2K Hold
143
– – ﹤0.01% 1051
2026
Q2
$66.6K Hold
143
– – ﹤0.01% 1030
2026
Q1
$54K Buy
+143
New +$61.2K ﹤0.01% 1045
2025
Q4
– Sell
-146
Closed -$65.4K – 822
2025
Q3
$65.4K Buy
+146
New +$66.1K ﹤0.01% 841
2025
Q2
– Sell
-161
Closed -$99.1K – 806
2025
Q1
$99.1K Buy
161
+56
+53% +$31.8K ﹤0.01% 751
2024
Q4
$55.6K Hold
105
– – ﹤0.01% 853
2024
Q3
$63.1K Sell
105
-78
-43% -$44.2K ﹤0.01% 830
2024
Q2
$117K Buy
183
+69
+61% +$39.5K ﹤0.01% 766
2024
Q1
$66.7K Buy
+114
New +$69.3K ﹤0.01% 810

Other funds holding CHE

Mather Group's CHE Position: Q3 2026 in Review

Mather Group held its Chemed (CHE) position steady in Q3 2026 at 143 shares worth $72.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Mather Group first reported a position in CHE in Q1 2024 and has held it in 9 quarters since. The position peaked at $117K in Q2 2024. 91 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • Mather Group held 143 shares of Chemed worth $72.2K as of Q3 2026.
  • Mather Group left its Chemed share count unchanged in Q3 2026.
  • Chemed made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1051 holding.
  • Mather Group first reported a position in Chemed in Q1 2024 and has held it in 9 quarters since.
  • Mather Group's Chemed position peaked at $117K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.